VivoSeq
Other

Surgical

0

Pipeline Programs

15

Active Trials

6

Companies Involved

Surgical is an early-stage landscape with 0 programs across 6 companies. The most active players are Johnson & Johnson Taiwan Ltd, Tafalgie Therapeutics, Pacira Pharmaceuticals, Inc.

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

23/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

79

clinical trials

Completed37 · 47%
Terminated11 · 14%
Unknown status9 · 11%
Recruiting9 · 11%
Withdrawn7 · 9%
Not yet recruiting2 · 3%
Other4 · 5%

Trial Activity

79 trials

Surgical Pembro +/- Olaparib w TMZ for rGBM
Recruiting··Phase 2·NCT05463848·78 enrolled
Minimally Invasive Non-surgical Therapy With or Without Injectable Bone Putty
Not yet recruiting··Phase 3·NCT06553222·30 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)